SCHEMBL8059615

SCHEMBL8059615

O=C(C=Cc1cccc(Cl)c1)Nc1cc(Cl)ccc1C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.65
KMT2A Q03164 5/20 0.65
MAPT P10636 4/20 0.65
ALDH1A1 P00352 3/20 0.65
HPGD P15428 2/20 0.65
POLB P06746 1/20 0.65
L3MBTL1 Q9Y468 1/20 0.65
NPC1 O15118 3/20 0.64
RAB9A P51151 3/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
CYP1A2 P05177 3/20 0.64
CYP3A4 P08684 2/20 0.64
CYP2C19 P33261 2/20 0.64
TRPA1 O75762 1/20 0.62
KCNK2 O95069 1/20 0.60
EGFR P00533 4/20 0.60
LMNA P02545 2/20 0.59
MMP1 P03956 5/20 0.58
MMP2 P08253 5/20 0.58
MMP9 P14780 5/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8059612 1.00 MEN1 (0.65) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL8060350 0.92 TRPA1 (0.73) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL8060354 0.92 TRPA1 (0.73) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL8063367 0.90 MEN1 (0.60) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL8065718 0.90 GRIK1 (0.61) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL8060347 0.90 GAA (0.61) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL8060344 0.90 GAA (0.61) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL8063364 0.90 MEN1 (0.60) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL8065719 0.90 GRIK1 (0.61) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL8059593 0.90 MEN1 (0.67) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed